3 reasons why Slater & Gordon Limited should be in your portfolio

Like Shine Corporate Ltd (ASX:SHJ), Slater & Gordon Limited (ASX:SGH) may have performed strongly in 2014 but 2015 looks to be more of the same.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shareholders in Australia's leading personal injury law firm Slater & Gordon Limited (ASX: SGH) enjoyed a stellar run throughout 2014 but by all accounts 2015 looks to be more of the same.

Indeed since listing in 2007 Slaters earnings per share (EPS) have more than doubled and its share price is up over 280%, but in the coming five years analysts are tipping EPS will continue growing rapidly.

Just this week, Morgans upped its price target on Slater to $7.31 per share, at current prices that represents 14% upside. But they're not alone. Last month CLSA also increased its price target on the lawyers to $7.22 per share.

Just like fellow legal eagles, Shine Corporate Ltd (ASX: SHJ) and IMF Bentham Ltd (ASX: IMF), Slater has many ways to grow.

Here're three reasons why Slater should be in your long-term portfolio.

  1. It's Australia's leading personal law firm. The Australian PI (personal injury) market is dominated by Slater, Shine and Maurice Blackburn. With around 25% market share, Slater may be 'ex-growth' in PI but its entrenched reputation affords it a defensive earnings base, which is independent of the direction of the economy. It'll continue to experience growth in PI, but it's likely to be slower than in previous years.
  2. General Law will fuel domestic growth. Slater is busy building its presence in General Law throughout Australia. This will build scale for the company and provide top line growth well into the medium-term.
  3. The UK expansion. Slater is growing acquisitively in the UK and establishing itself a premier law firm in multi-track cases. It has an estimated 5% market share (2% behind its largest rival) and the opportunities for consolidation are significant. To put it in perspective, from this small market share it expects to derive 45% of group revenues in 2015.

I'm already well up on my investment in all three of these legal eagles. However, at today's price of $6.40, Slater & Gordon is a good long-term buy in my opinion. Whilst its 1.4% dividend might not seem like much now, after five years of growth, I expect its payout will become meaningfully larger.

Motley Fool Contributor Owen Raszkiewicz owns shares of Slater & Gordon, Shine Corporate and IMF Bentham. You can follow Owen on Twitter @ASXinvest.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »